Camance, Aidelyn C.
HRN: 29-27-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/12/2026
07/19/2026
IV
2.25g
Q6
Cap Hr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes